Page last updated: 2024-10-17

lactic acid and Granulocytic Leukemia, Chronic

lactic acid has been researched along with Granulocytic Leukemia, Chronic in 7 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Guo, B1
Pomicter, AD1
Li, F1
Bhatt, S1
Chen, C1
Li, W1
Qi, M1
Huang, C1
Deininger, MW1
Kong, MG1
Chen, HL1
Gayatri, MB1
Kancha, RK1
Patchva, D1
Velugonda, N1
Gundeti, S1
Reddy, ABM1
De Rosa, V1
Monti, M1
Terlizzi, C1
Fonti, R1
Del Vecchio, S1
Iommelli, F1
Gavrilov, K1
Seo, YE1
Tietjen, GT1
Cui, J1
Cheng, CJ1
Saltzman, WM1
Klawitter, J2
Kominsky, DJ1
Brown, JL1
Christians, U1
Leibfritz, D1
Melo, JV1
Eckhardt, SG1
Serkova, NJ1
Acharya, S1
Sahoo, SK1
SANTAGATI, U1
BOLDRINI, R1

Other Studies

7 other studies available for lactic acid and Granulocytic Leukemia, Chronic

ArticleYear
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 12-21, Volume: 118, Issue:51

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Humans; Lactic Acid; Leukemia, Experimental; Leukemia, My

2021
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
    The FEBS journal, 2023, Volume: 290, Issue:18

    Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Glucose; Humans; Ima

2023
Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells.
    International journal of molecular sciences, 2019, Jun-27, Volume: 20, Issue:13

    Topics: Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cyclin D1; Glycolysis; Humans; Imatinib Mesylate

2019
Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Dec-01, Volume: 112, Issue:48

    Topics: Apoptosis; Base Sequence; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Fus

2015
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells.
    British journal of pharmacology, 2009, Volume: 158, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferatio

2009
Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy.
    Biomaterials, 2011, Volume: 32, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferatio

2011
[Behavior of sugar, pyruvic acid and lactic acid in blood in lymphadenosis and chronic myeloid leukemia].
    Il Progresso medico, 1955, May-31, Volume: 11, Issue:10

    Topics: Blood Glucose; Humans; Lactic Acid; Leukemia; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BC

1955